7-hydroxy-4h-thieno[3,2-b]pyridin-5-on derivative and use thereof
KR20200030466A
7-hydroxy-4h-thieno[3,2-b]pyridin-5-one derivatives and methods of use of thereof
KR20210028339A
Pharmaceutical composition using hdac inhibitor and anti pd-1 antibody or anti pd-l1 antibody
WO2019190214A1
Pharmaceutical composition for prevention or treatment of fibrosis
KR20190113639A
Pharmaceutical composition for preventing or treating fibrosis
KR20200090359A
PHARMACEUTICAL COMPOSITION FOR INTRAVENEOUS COMPRISING Fab I INHIBITOR AND PREPARATION METHOD THEREOF
KR20200047996A
Alkylcarbamoyl naphthalenyloxy octenoyl hydroxyamide phosphate, alkylcarbamoyl naphthalenyloxy octenoyl hydroxyamide tartrate or combination thereof and preparing method thereof
KR20200009744A
PHARMACEUTICAL COMPOSITION FOR ORAL COMPRISING Fab I INHIBITOR AND PREPARATION METHOD THEREOF
EP3682876A1
Pharmaceutical composition for treating acute and chronic pain, containing polmacoxib and tramadol
KR20190114403A
Pharmaceutical composition comprising polmacoxib and pregabalin for treatment of pain
KR20190111227A
Preparation for percutaneous absorption
KR20190107987A
Stabilized Injectable Solution Composition Containing Polmacoxib and Preparation Method Thereof
KR20190045026A
A stability-enhanced tablet formulation of pregabalin
US2018008571A1
Oral pharmacological composition including 5-{4-(amino sulfonyl)phenyl}-2,2-dimethyl-4-(3-fluorophenyl)-3(2H)-furanone having crystalline structure with excellent stability
KR20180136741A
Pharmaceutically acceptable salts of alkylcarbamoyl naphthalenyloxy octenoylhydroxyamide or derivatives thereof and preparing method thereof
KR20170135163A
microsphere type controlled-release formulation for treating arthritis comprising polmacoxib
KR20160112732A
Pharmaceutical compositions comprising potassium salt of telmisartan and Preparation methods thereof
KR20160014987A
Instillations formulation for treating ocular infections comprising pyridin-2-one derivatives
KR101446601B1
Pharmaceutical composition and capsule formulation comprising 5-(4-(aminosulfonyl)phenyl)-2,2-dimethyl-4-(3-fluorophenyl)-3(2h)-furanone
CN104995184A
2,3-dihydro-isoindole-1-on derivative as BTK kinase suppressant, and pharmaceutical composition including same
